Clinical trials
Graft vs Host Disease trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2012 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 13 |
| Completed | 9 |
| Terminated | 5 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hadassah Medical Organization | 9 |
| Rabin Medical Center | 4 |
| Sheba Medical Center | 4 |
| Incyte Corporation | 3 |
| Novartis Pharmaceuticals | 2 |
| Eli Sprecher, MD | 1 |
| Equillium | 1 |
| Kiadis Pharma | 1 |
| Pharmacyclics LLC. | 1 |
| Rafa Laboratories | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 29 |
| Bronchiolitis Obliterans Syndrome | 5 |
| Hematologic Neoplasms | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Immune System Diseases | 1 |
| Myelodysplastic Syndromes | 1 |
| Polycythemia Vera | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Primary Myelofibrosis | 1 |
| Thalassemia | 1 |
Trials
Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.